Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Head and Neck Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07126457
What this trial is testing

Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things

Who this might be right for
Head and Neck CancerRadiation-Induced Mucositis
Nanfang Hospital, Southern Medical University 110
Not applicableWithdrawnNCT04040673
What this trial is testing

RAman For Thyroid cancER

Who this might be right for
Thyroid DiseasesThyroid Cancer
Gloucestershire Hospitals NHS Foundation Trust
Not applicableLooking for participantsNCT05319483
What this trial is testing

The Clinical, Epidemiological and Treatment Characteristics of Head and Neck Cancer Patients

Who this might be right for
Waiting Times, Patient Pathways, Effect of Lifestyle-related, Clinical and Demographic Parameters on Outcomes
University of Pecs 100
Testing effectiveness (Phase 2)Study completedNCT03878979
What this trial is testing

Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerHead and Neck Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Not applicableWithdrawnNCT04276454
What this trial is testing

Lymphedema Treatment in Head and Neck Cancer Patients

Who this might be right for
Head and Neck Cancer
Endeavor Health
Testing effectiveness (Phase 2)Study completedNCT00611754
What this trial is testing

Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Sanofi 15
Large-scale testing (Phase 3)Looking for participantsNCT06248996
What this trial is testing

A Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Lund University Hospital 308
Not applicableLooking for participantsNCT07131566
What this trial is testing

Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
Lars Olaf Cardell 500
Testing effectiveness (Phase 2)Study completedNCT02538510
What this trial is testing

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Nasopharynx Carcinoma+12 more
University of Washington 50
Early research (Phase 1)Ended earlyNCT01212627
What this trial is testing

Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Angela Taber MD 12
Testing effectiveness (Phase 2)Study completedNCT02499120
What this trial is testing

Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Pfizer 125
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06793761
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC

Who this might be right for
Head and Neck Cancer
Beijing Tongren Hospital 260
Not applicableLooking for participantsNCT06636188
What this trial is testing

An Oncology Nurse AI Agent to Reduce Cancer Distress During Radiotherapy

Who this might be right for
Head and Neck Cancer
The University of Hong Kong 138
Large-scale testing (Phase 3)UnknownNCT00603759
What this trial is testing

COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma

Who this might be right for
Head and Neck Cancer
Tehran University of Medical Sciences 122
Early research (Phase 1)Ended earlyNCT03265080
What this trial is testing

ADXS-NEO Expressing Personalized Tumor Antigens

Who this might be right for
Colon Cancer MetastaticHead and Neck Cancer MetastaticMetastatic Non-Small Cell Lung Cancer+2 more
Advaxis, Inc. 13
Large-scale testing (Phase 3)Study completedNCT00120211
What this trial is testing

Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
International Atomic Energy Agency 855
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06876038
What this trial is testing

Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

Who this might be right for
Oral CancerOral Cavity CancerOral Leukoplakia+2 more
University of Massachusetts, Boston 65
Testing effectiveness (Phase 2)Study completedNCT00410826
What this trial is testing

Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+7 more
University of Washington 204
Testing effectiveness (Phase 2)Study completedNCT04207918
What this trial is testing

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Who this might be right for
Esophageal CancerChemoradiotherapyNimotuzumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Testing effectiveness (Phase 2)Study completedNCT01693718
What this trial is testing

Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck
University of Chicago 44
Next Page